JP2014533241A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533241A5
JP2014533241A5 JP2014539111A JP2014539111A JP2014533241A5 JP 2014533241 A5 JP2014533241 A5 JP 2014533241A5 JP 2014539111 A JP2014539111 A JP 2014539111A JP 2014539111 A JP2014539111 A JP 2014539111A JP 2014533241 A5 JP2014533241 A5 JP 2014533241A5
Authority
JP
Japan
Prior art keywords
patent document
application publication
patent application
insulin
prior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014539111A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533241A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/062423 external-priority patent/WO2013063572A1/en
Publication of JP2014533241A publication Critical patent/JP2014533241A/ja
Publication of JP2014533241A5 publication Critical patent/JP2014533241A5/ja
Pending legal-status Critical Current

Links

JP2014539111A 2011-10-27 2012-10-29 超濃縮速効型インスリン類似体製剤 Pending JP2014533241A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552246P 2011-10-27 2011-10-27
US61/552,246 2011-10-27
PCT/US2012/062423 WO2013063572A1 (en) 2011-10-27 2012-10-29 Ultra-concentrated rapid-acting insulin analogue formulations

Publications (2)

Publication Number Publication Date
JP2014533241A JP2014533241A (ja) 2014-12-11
JP2014533241A5 true JP2014533241A5 (cg-RX-API-DMAC7.html) 2015-12-17

Family

ID=48168643

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014539111A Pending JP2014533241A (ja) 2011-10-27 2012-10-29 超濃縮速効型インスリン類似体製剤

Country Status (10)

Country Link
US (1) US9908925B2 (cg-RX-API-DMAC7.html)
EP (1) EP2771026A4 (cg-RX-API-DMAC7.html)
JP (1) JP2014533241A (cg-RX-API-DMAC7.html)
KR (1) KR20150021011A (cg-RX-API-DMAC7.html)
CN (1) CN104010652A (cg-RX-API-DMAC7.html)
AU (1) AU2012328407A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014010139A2 (cg-RX-API-DMAC7.html)
IN (1) IN2014CN03888A (cg-RX-API-DMAC7.html)
SG (1) SG11201401835VA (cg-RX-API-DMAC7.html)
WO (1) WO2013063572A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105008395B (zh) * 2012-11-05 2020-12-29 卡斯西部储备大学 长效单链胰岛素类似物
CN106102763A (zh) 2014-01-13 2016-11-09 塞尔玛琳糖尿病有限责任公司 速效胰岛素制剂和药物递送系统
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
CA2964918A1 (en) * 2014-10-20 2016-04-28 Case Western Reserve University Halogenated insulin analogues of enhanced biological potency
SG10201809427SA (en) * 2014-11-21 2018-11-29 Merck Sharp & Dohme Insulin receptor partial agonists
WO2016105545A2 (en) * 2014-12-24 2016-06-30 Case Western Reserve University Insulin analogues with enhanced stabilized and reduced mitogenicity
WO2017032795A1 (en) 2015-08-25 2017-03-02 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
EP3341403B1 (en) 2015-08-25 2022-01-05 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
CN108368163A (zh) 2015-08-25 2018-08-03 诺和诺德股份有限公司 新型胰岛素衍生物及其医学用途
WO2017070617A1 (en) * 2015-10-21 2017-04-27 Case Western Reserve University Diol-modified insulin analogues containing a glucose-regulated conformational switch
HK1255634A1 (zh) * 2015-12-23 2019-08-23 Case Western Reserve University 超稳胰岛素类似物在聚合物熔体中的包囊
EP3893934B1 (en) * 2018-12-11 2025-09-10 Sanofi Insulin conjugates
IL319162A (en) 2019-12-11 2025-04-01 Novo Nordisk As New insulin analogs and their use
WO2024194897A1 (en) * 2023-03-22 2024-09-26 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) A glycation resistant insulin polypeptide and a method of preparing the same thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992418A (en) 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
EP0425482B1 (en) 1988-07-20 1993-08-18 Novo Nordisk A/S Human insulin analogs and preparations containing them
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US20030104981A1 (en) * 1995-11-03 2003-06-05 Jelena Mandic Human insulin analogues
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
US7317000B2 (en) 2001-12-02 2008-01-08 Novo Nordisk A/S Glucose-dependent insulins
EP1453860A2 (en) * 2001-12-02 2004-09-08 Novo Nordisk A/S Novel glucose-dependant insulins
CA2522818A1 (en) * 2003-03-11 2004-09-23 Soren Ostergaard Pharmaceutical preparations comprising acid-stabilised insulin
SE0401942D0 (sv) 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
JP2008510692A (ja) 2004-08-20 2008-04-10 ノボ ノルディスク アクティーゼルスカブ 薬学的に活性なインスリン受容体調節分子
ES2554773T3 (es) * 2006-10-04 2015-12-23 Case Western Reserve University Insulina y análogos de la insulina resistentes a la fibrilación
MX2010005317A (es) * 2007-11-20 2010-06-02 Ambrx Inc Polipeptidos de insulina modificados y sus usos.
NZ590792A (en) * 2008-07-31 2012-12-21 Univ Case Western Reserve Halogen-stabilized insulin
KR20120129875A (ko) 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 염소화 아미노산을 갖는 인슐린 유사체
CA2747490C (en) * 2008-12-19 2017-02-14 Indiana University Research And Technology Corporation Insulin analogs

Similar Documents

Publication Publication Date Title
JP2014533241A5 (cg-RX-API-DMAC7.html)
JP2014519662A5 (cg-RX-API-DMAC7.html)
JP2014513484A5 (cg-RX-API-DMAC7.html)
JP2013517798A5 (cg-RX-API-DMAC7.html)
JP2014525291A5 (cg-RX-API-DMAC7.html)
CY1123270T1 (el) Υποκατεστημενες ενωσεις βενζαλδεϋδης και μεθοδοι για τη χρηση τους στην αυξηση της οξυγονωσης των ιστων
JP2014521827A5 (cg-RX-API-DMAC7.html)
JP2013540293A5 (cg-RX-API-DMAC7.html)
JP2014532727A5 (cg-RX-API-DMAC7.html)
CY1118442T1 (el) Μεθοδοι αγωγης δια της χρησεως εκλεκτικων αναστολεων bcl-2
JP2014520155A5 (cg-RX-API-DMAC7.html)
JP2017515162A5 (cg-RX-API-DMAC7.html)
JP2013519136A5 (cg-RX-API-DMAC7.html)
JP2015522045A5 (cg-RX-API-DMAC7.html)
JP2013532488A5 (cg-RX-API-DMAC7.html)
JP2016506366A5 (cg-RX-API-DMAC7.html)
JP2014509874A5 (cg-RX-API-DMAC7.html)
JP2013214010A5 (cg-RX-API-DMAC7.html)
JP2013539454A5 (cg-RX-API-DMAC7.html)
JP2011528248A5 (cg-RX-API-DMAC7.html)
JP2013532130A5 (cg-RX-API-DMAC7.html)
JP2014502322A5 (cg-RX-API-DMAC7.html)
JP2016506003A5 (cg-RX-API-DMAC7.html)
JP2012094862A5 (cg-RX-API-DMAC7.html)
JP2015510508A5 (cg-RX-API-DMAC7.html)